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Introduction 
The association between low plasma dehydroepiandrosterone (DHEA) levels and the increased risk of cardiovascular 
disease (CVD) is well known.  However, DHEA’s ergogenic influence is less well known.  Supraphysiological 
dosages may be necessary for enhanced performance in young healthy adults.  Subsequently, the current study 
examined the effects of short-term (21 day) DHEA supplementation on cardiac and skeletal muscle function. 
 
Methods 
Sixteen adult male Wistar rats (401  8g) were randomly allocated to receive a daily, subcutaneous injection of 
placebo (sesame oil) or DHEA (50 ml·kg
-1
 in DMSO and sesame oil) for 21 days.  Body mass, food and water 
consumption were recorded daily throughout the supplementation period.  Following the supplementation period, 
animals were anaesthetised (CO2) and a venous blood sample collected for serum DHEA analysis.  Animals were 
killed by exsanguination and the soleus, extensor digitorum longus (EDL), left atrium (LA) and right atrium (RA) of the 
heart removed.  The tissues were suspended in organ baths for the recording of force of contraction (FOC) and/or 
rate of contraction (ROC).  Concentration response curves to isoprenaline (LA, RA) and calcium (LA) were 
determined.  Maximum single twitch FOC, maximum tetanic FOC and fatigability were determined in both skeletal 
muscle tissues.  Significant (P<0.05) differences between control and DHEA groups were determined by a Mann-
Whitney U test due to the small sample size. 
 
Results 
DHEA supplementation resulted in a significantly greater serum DHEA level, significantly greater basal LA FOC, 
reduced RA ROC (p<0.074), significantly greater EDL single and tetanic maximum FOC, significantly greater EDL 
FOC at 50% fatigue and significantly reduced food consumption and body mass gain (Table 1).   
 
Table 1: Hormone, cardiac and skeletal muscle function for the control and DHEA supplementation groups. 
 control (n=8) DHEA (n=8) 
Serum DHEA (ng·mL
-1
)          0.9  3.8     424.9  3.8*** 
Basal LA FOC (mN)        3.23  0.20         4.2  0.3* 
Basal RA ROC (bpm)         221  5        204  7
#
 
EDL single max (mN)        86.9  6.7     105.2  6.7* 
EDL tetanic max (mN)      358.9  27.3     453.4  33.5* 
EDL at 50% fatigue (mN)      192.2  11.1     248.3  22.8* 
Average daily food consumption (g)        36.1  1.8       31.3  0.8* 
Body mass gain 
                   - absolute (g) 
                   - relative to initial mass (%) 
 
       37.3  3.8 
         9.3  0.8 
 
        9.1  3.6** 
        2.3  0.8** 
Mean  SE; 
#
 P<0.074, * P<0.05, ** P<0.01, *** P<0.001 vs Control 
 
Discussion/Conclusion 
The current results demonstrated that short-term, supraphysiological DHEA supplementation significantly reduced 
mass gain, significantly increased basal cardiac muscle function and significantly increased skeletal muscle (EDL) 
function.  The cardioprotective nature of DHEA may result from its alteration in body mass possibly via altered lipid 
metabolism and improved cardiac contractility, while the possible ergogenic effects of DHEA may be mediated by 
increases in FOC for skeletal muscles predominantly of Type II fibres. 
 
